v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities    
Net income $ 14,458 $ 2,987
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 4,197 4,702
Amortization of debt issuance costs 351 308
Share-based compensation 1,346 1,058
Unrealized gain from investment in equity securities (9) (162)
Loss (income) from equity method investments 677 (2,054)
Deferred tax (921) (1,915)
Changes in operating assets and liabilities, net of business combinations:    
Receivables, net (9,390) (7,043)
Receivables, net – related parties (17,612) (2,774)
Other receivables (223) 521
Prepaid expenses and other current assets 7,165 (1,495)
Right-of-use assets 836 794
Other assets (192) (4,801)
Accounts payable and accrued expenses 3,915 (7,173)
Fiduciary accounts payable (2,771) (318)
Medical liabilities 1,149 4,973
Income taxes payable 7,835 3,505
Operating lease liabilities (859) (406)
Net cash provided by (used in) operating activities 9,952 (9,293)
Cash flows from investing activities    
Proceeds from repayment of loans receivable – related parties 16 0
Proceeds from sale of marketable securities 1,106 0
Purchases of marketable securities (332) (374)
Purchase of investment – equity method 0 (300)
Purchases of property and equipment (98) (269)
Net cash provided by (used in) investing activities 692 (943)
Cash flows from financing activities    
Dividends paid (4) (9,934)
Repayment of term loan (2,434) (2,375)
Payment of finance lease obligations (27) (26)
Proceeds from the exercise of stock options and warrants 4,256 700
Repurchase of shares (342) (426)
Purchase of noncontrolling interest (225) 0
Proceeds from sale of noncontrolling interest 38 0
Net cash provided by (used in) financing activities 1,262 (12,061)
Net increase (decrease) in cash, cash equivalents, and restricted cash 11,906 (22,297)
Cash, cash equivalents, and restricted cash, beginning of period 193,970 104,010
Cash, cash equivalents, and restricted cash, end of period 205,876 81,713
Supplementary disclosures of cash flow information:    
Cash paid for income taxes 40 0
Cash paid for interest 1,277 2,619
Supplemental disclosures of non-cash investing and financing activities    
Cancellation of restricted stock awards 144 0
Reconciliation of cash, cash equivalents, and restricted cash    
Cash, cash equivalents, restricted cash total $ 205,876 $ 81,713

Source